Key Takeaway: Jonathan C. Javitt, M.D., M.P.H., the Founder and CEO of NRx Pharmaceuticals, discusses the potential of HOPE Therapeutics in combating suicidality and mental health issues. He highlights the establishment of a nationwide network of interventional psychiatry clinics. Additionally, he mentions planned financing and upcoming presentations in San Francisco and Mar-A-Lago.
Price reaction · baseline $3.805 (2025-01-08T20:42:00.000Z) · hit during market hours · 3 other NRXP headline(s) in the window, move may be shared
day 0 close · peak
-1.2%
Market Sentiment Analysis
POSITIVE FACTORS
Focus on addressing the national epidemic of suicidality.
Development of a nationwide network of interventional psychiatry clinics.
Upcoming presentations indicate proactive engagement with stakeholders.
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+167%
120-day peak, hindsight
Typical move
4.3%
average across 2 past catalysts
Cash runway
~12 mo
Low dilution risk
Lead asset
NRX-101
Phase 2 · Bipolar Depression
Full Press Release Details
The Big Biz Show interviews Jonathan C. Javitt, M.D., M.P.H. Founder, Chairman and CEO of NRx Pharmaceuticals and Co-CEO of HOPE Therapeutics, discussing the opportunity for HOPE Therapeutics in developing its nationwide network of interventional psychiatry clinics to help address the national epidemic of suicidality and mental health, the planned financing and upcoming presentations by management in San Francisco and at Mar-A-Lago.
Frequently Asked Questions
What is the focus of HOPE Therapeutics?
HOPE Therapeutics aims to address the national epidemic of suicidality and mental health.
Who is Jonathan C. Javitt?
Jonathan C. Javitt is the Founder, Chairman, and CEO of NRx Pharmaceuticals.
What upcoming events are mentioned in the interview?
The interview mentions upcoming presentations in San Francisco and at Mar-A-Lago.
What is the planned financing for?
The planned financing is related to the development of interventional psychiatry clinics.